Related Experiment Video
Updated: Nov 1, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Essential tremor (ET) affects millions, often mistaken for Parkinson's disease. Emerging treatments offer new hope for those with this debilitating condition.
Area of Science:
- Neurology
- Movement Disorders
Background:
- Essential tremor (ET) is a prevalent neurological condition affecting an estimated ten million individuals in the United States.
- Despite being recognized for over a century, ET often suffers from low public and medical awareness, frequently being misdiagnosed as Parkinson's disease.
- ET manifests as involuntary shaking, primarily in the arms and hands, but can also affect the head and torso, significantly impacting daily activities.
Purpose of the Study:
- To highlight the prevalence and impact of essential tremor.
- To discuss the challenges in diagnosing and recognizing ET as a distinct condition.
- To introduce the emergence of novel therapeutic approaches for ET management.
Main Methods:
- Review of existing literature on essential tremor prevalence and symptomatology.
- Analysis of diagnostic challenges and common misdiagnoses, particularly with Parkinson's disease.
- Exploration of recent advancements in treatment strategies for ET.
Main Results:
- Essential tremor impacts a substantial portion of the US population, yet remains underrecognized.
- The condition's symptoms can severely impair fine motor skills required for daily tasks such as writing and eating.
- New treatment modalities are becoming available, potentially improving quality of life for affected individuals.
Conclusions:
- Increased awareness and accurate diagnosis of essential tremor are crucial.
- The development of new treatments holds promise for managing ET symptoms.
- Further research and patient education are needed to address the impact of essential tremor.
More Related Videos
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Electroconvulsive Therapy
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...